Channel Therapeutics Corporation

Channel Therapeutics Corporation

CHRO
Channel Therapeutics CorporationUS flagNew York Stock Exchange Arca
1.35
USD
+0.09
- -
8.90MMarket Cap

Channel Therapeutics Corporation (CHRO) Stock Split History

Learn about Channel Therapeutics Corporation's most recent 1-for-10 basis stock split on July 02, 2025. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Channel Therapeutics Corporation's most recent stock split

Split Date: 2025-07-02
Split Ratio: 1:10
Price Before Split: $1.65
Price After Split: $0.17

Developer API

Get CHRO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CHRO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Channel Therapeutics Corporation's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-07-021:10Yes$1.65$0.17

About Channel Therapeutics Corporation

Company overview and industry information

Channel Therapeutics Corporation (CHRO) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Channel Therapeutics Corporation Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.